Clinical Trials
3 trialsNCT06177171 2026-05-27
Olaparib and ASTX727 in BRCA1/2- and Homologous Recombination Deficient (HRD)-Mutated Tumors
University of California, San Francisco
Phase 1 Recruiting
NCT05420064 2025-11-12
An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test Results
Memorial Sloan Kettering Cancer Center
Phase NA Recruiting
NCT01630226 2012-07-12
Cisplatin-monotherapy in the Treatment of BRCA1 Positive Breast Cancer Patients in Poland
Pomeranian Medical University Szczecin
Phase 2 Unknown